Products & Services · Net Sales

Neuro Cranial — Net Sales

Stryker Neuro Cranial — Net Sales increased by 3.4% to $1.27B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 44.4%, from $882.00M to $1.27B. Over 3 years (FY 2021 to FY 2024), Neuro Cranial — Net Sales shows an upward trend with a 20.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ3 2025
Rolls up toTotal Revenue

How to read this metric

An increase indicates strong adoption of neurosurgical technologies and successful market expansion, while a decrease may signal increased competition or a slowdown in elective neuro-cranial procedures.

Detailed definition

This metric represents the total revenue generated from the sale of neurosurgical and cranial products, including specia...

Peer comparison

Peers in the medical technology space report similar segment-specific revenue for neuro-interventional and cranial surgery divisions, often benchmarked against overall market growth rates for neuro-surgical procedures.

Metric ID: syk_segment_neuro_cranial_net_sales

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$620.00M$598.00M$648.00M$646.00M$674.00M$664.00M$768.00M$710.00M$746.00M$768.00M$874.00M$760.00M$832.00M$882.00M$1.80B$1.13B$1.23B$1.27B
QoQ Change-3.5%+8.4%-0.3%+4.3%-1.5%+15.7%-7.6%+5.1%+2.9%+13.8%-13.0%+9.5%+6.0%+103.9%-37.4%+9.4%+3.4%
YoY Change+8.7%+11.0%+18.5%+9.9%+10.7%+15.7%+13.8%+7.0%+11.5%+14.8%+105.7%+48.2%+48.1%+44.4%
Range$598.00M$1.80B
CAGR+18.5%
Avg YoY Growth+26.3%
Median YoY Growth+14.3%
Current Streak2 quarters growth

Frequently Asked Questions

What is Stryker's neuro cranial — net sales?
Stryker (SYK) reported neuro cranial — net sales of $1.27B in Q3 2025.
How has Stryker's neuro cranial — net sales changed year-over-year?
Stryker's neuro cranial — net sales increased by 44.4% year-over-year, from $882.00M to $1.27B.
What is the long-term trend for Stryker's neuro cranial — net sales?
Over 3 years (2021 to 2024), Stryker's neuro cranial — net sales has grown at a 20.7% compound annual growth rate (CAGR), from $2.43B to $4.27B.
What does neuro cranial — net sales mean?
Total revenue generated from the sale of neurosurgical and cranial medical devices and equipment.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.